General Information of Drug (ID: DMTCKLX)

Drug Name
RE-024
Synonyms
fosmetpantotenate; Fosmetpantotenate; Fosmetpantotenate [USAN]; Fosmetpantotenate (USAN); 1858268-66-2; SCHEMBL15346116; CHEMBL3989938; HUWUHKIPYXWUPN-YVRVQSMLSA-N; D10934; methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl)amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate; methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl)amino)(phenoxy) phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate; Dimethyl 8-hydroxy-2,7,7-trimethyl-4,9-dioxo-4-phenoxy-5-oxa-3,10-diaza-4-lambda5-phosphatridecanedioate
Indication
Disease Entry ICD 11 Status REF
Neurodegenerative disorder 8A20-8A23 Phase 3 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C20H31N2O9P
Canonical SMILES
CC(C(=O)OC)NP(=O)(OCC(C)(C)C(C(=O)NCCC(=O)OC)O)OC1=CC=CC=C1
InChI
1S/C20H31N2O9P/c1-14(19(26)29-5)22-32(27,31-15-9-7-6-8-10-15)30-13-20(2,3)17(24)18(25)21-12-11-16(23)28-4/h6-10,14,17,24H,11-13H2,1-5H3,(H,21,25)(H,22,27)/t14-,17-,32?/m0/s1
InChIKey
HUWUHKIPYXWUPN-YVRVQSMLSA-N
Cross-matching ID
PubChem CID
71811909
CAS Number
1858268-66-2
TTD ID
D01RBP

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)